Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden

Background Sweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23–29 years and primary human papillomavirus (HPV) testing for women aged 30–64 years; however, alternative strategies may be preferred. To inform cervical cancer prevention p...

Full description

Bibliographic Details
Main Authors: Sara Fogelberg, Mark S. Clements, Kine Pedersen, Stephen Sy, Pär Sparén, Jane J. Kim, Emily A. Burger, Magdalena Grce
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526933/?tool=EBI